Tech in Diabetes: What’s Going Wrong?
ORLANDO — Technologic advances aren’t fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. “We
ORLANDO — Technologic advances aren’t fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. “We
Curious bits of DNA tucked inside genomes across all kingdoms of life historically have been disregarded since they don’t seem to have a role to
Louisiana became the first state to enact a law that classifies the abortion-inducing drugs mifepristone and misoprostol as schedule IV drugs, meaning they are considered